ArticleSaudi medical journal2014

Does combined peroxisome proliferator-activated receptors-agonist and pravastatin therapy attenuate the onset of diabetes-induced experimental nephropathy?

Hayam I GadPubMed ↗Full text ↗

No numbers read from the abstract.